The enzyme activation-induced deaminase (AID) deaminates deoxycytidine at the immunoglobulin genes, thereby initiating antibody affinity maturation and isotype class switching during immune responses. In contrast, off-target DNA damage caused by AID is oncogenic. Central to balancing immunity and cancer is AID regulation, including the mechanisms determining AID protein levels. We describe a specific functional interaction between AID and the Hsp40 DnaJa1, which provides insight into the function of both proteins. Although both major cytoplasmic type I Hsp40s, DnaJa1 and DnaJa2, are induced upon B-cell activation and interact with AID in vitro, only DnaJa1 overexpression increases AID levels and biological activity in cell lines. Conversely, DnaJa1, but not DnaJa2, depletion reduces AID levels, stability and isotype switching. In vivo, DnaJa1-deficient mice display compromised response to immunization, AID protein and isotype switching levels being reduced by half. Moreover, DnaJa1 farnesylation is required to maintain, and farnesyltransferase inhibition reduces, AID protein levels in B cells. Thus, DnaJa1 is a limiting factor that plays a nonredundant role in the functional stabilization of AID.
Introduction
Naive B lymphocytes display the prediversified primary repertoire of antibodies. Antibody responses are initiated when a few of them recognize their cognate antigen and proliferate. To be effective, the antibodies produced by the selected B-cell clones still need to undergo affinity maturation to better recognize the antigen; as well as isotype switching to change the default IgM isotype for IgG, IgE or IgA. Antibody affinity maturation and isotype switching absolutely depend on activation-induced deaminase (AID) Revy et al, 2000) .
AID deaminates deoxycytidine to deoxyuridine at defined regions of the immunoglobulin (Ig) genes, which initiates somatic hypermutation or gene conversion, the molecular pathways underpinning antibody affinity maturation, as well as class switch recombination (CSR) (Di Noia and Neuberger, 2007; Peled et al, 2008; Stavnezer et al, 2008) . AID deficiency compromises the antibody response resulting in a Hyper-IgM immunodeficiency syndrome (Revy et al, 2000) . On the other hand, AID contributes to antibody-mediated autoimmune diseases (Zaheen and Martin, 2011) as well as to cancer (Okazaki et al, 2003; Pasqualucci et al, 2008) . The latter ensues from AID mutating tumour suppressor and (proto)-oncogenes as well as from initiating chromosomal translocations as byproducts of CSR (Pasqualucci et al, 2001; Ramiro et al, 2004; Liu et al, 2008; Robbiani et al, 2008; Yamane et al, 2011) . A number of regulatory pathways enforcing an appropriate AID expression pattern, optimal AID mRNA and protein levels as well as modulating its access to the nucleus, favour AID physiological functions over its pathological effects (reviewed in Stavnezer, 2011; Storck et al, 2011) .
AID post-translational regulation is important for two reasons. First, because upwards and downwards variations in AID levels impact the frequency of both antibody diversification and pathological byproducts (Sernández et al, 2008; Teng et al, 2008; Robbiani et al, 2009; Orthwein et al, 2010) . Second, because physiological and pathological expression of AID outside germinal centre B cells is well documented (Morgan et al, 2004; Pasqualucci et al, 2004; Matsumoto et al, 2007; Macduff et al, 2009; Pauklin et al, 2009; Kuraoka et al, 2011) . Prominent among AID regulation are subcellular localization and protein stability, which are linked mechanisms that limit AID access to the genome. Indeed, AID is a nucleo-cytoplasmic shuttling protein but most of AID is in the cytoplasm in steady state because nuclear export plus cytoplasmic retention outcompete nuclear import (Brar et al, 2004; Ito et al, 2004; McBride et al, 2004; Patenaude et al, 2009; Patenaude and Di Noia, 2010) . In turn, cytoplasmic AID is more stable than nuclear AID (Aoufouchi et al, 2008; Orthwein et al, 2010) . We have shown that AID is stabilized in the cytoplasm by the chaperone Hsp90, which helps explaining the differences in AID stability depending on its localization (Orthwein et al, 2010) . We now describe a key role for the Hsp40 DnaJa1 in determining AID protein levels and stability.
The prototypical Hsp40 is Escherichia coli DnaJ, a cochaperone of the bacterial Hsp70 DnaK (Langer et al, 1992) . DnaJ is but one member of a large protein family characterized by the J-domain, which stimulates the ATPase activity of Hsp70 as part of a chaperoning cycle that allows folding, conformational changes, degradation and transport across membranes (Walsh et al, 2004; Qiu et al, 2006; Kampinga and Craig, 2010) . The human genome encodes for 41 J-domain proteins, which can be divided into three groups (Qiu et al, 2006; Kampinga and Craig, 2010) . Type I J-proteins or DjAs (DnaJa1-4) are orthologues of E. coli DnaJ and yeast Ydj1. DjAs have an N-terminal J-domain separated by a Gly/Pherich linker from the C-terminal substrate-binding region. This region contains three distinct structural domains revealed by the Ydj1 crystal structures (Li et al, 2003; Wu et al, 2005) (Supplementary Figure S1) : CTDI, has a hydrophobic pocket that binds certain peptides found in a subset of Ydj1 substrates; CTDII, is made of two Zn-fingers; and CTDIII, which contains most residues involved in DjA dimerization. Additionally, like YdJ1, cytoplasmic DjAs have a short Cterminal extension ending in a farnesylation motive (Kanazawa et al, 1997) . Type II J-proteins or DjBs (13 members in humans) are orthologues of yeast Sis1 and have CTDI and CTDIII structurally homologous to DjA's (Sha et al, 2000) but lack Zn-fingers. Type III J-proteins are very heterogeneous in structure, size and function sharing only the J-domain. Only DjAs and some DjBs behave as Hsp70 cochaperones similarly to DnaJ, Ydj1 or Sis1 (Qiu et al, 2006; Kampinga and Craig, 2010) . Some DjAs additionally work in the Hsp90-mediated stabilization pathway (Caplan et al, 1995; Kimura et al, 1995; Hernández et al, 2002) .
The expansion and divergence of J-protein paralogs during evolution contrast with the conservation of many orthologues across vertebrate species (f.i. DnaJa1 is 495% identical between most vertebrates). This is likely to reflect functional specialization and presumably some specific subset of substrates in vivo, the mechanistic details of which as well as the identity of the substrates are largely unknown (Kampinga and Craig, 2010) . In-vitro folding experiments have shown some redundancy but also clear functional differences between the major mammalian cytosolic Hsp40s (DnaJa1, DnaJa2, Dnaja4, DnaJb1) (Terada and Mori, 2000; Bhangoo et al, 2007; Tzankov et al, 2008; Walker et al, 2010) . The different phenotypes of mice deficient for DnaJa1 (Terada et al, 2005) and DnaJb1 (Uchiyama et al, 2006) support this view but have not provided yet the identity of any substrates that would depend on one particular Hsp40. Here, we identify DnaJa1 as a specific limiting factor in determining AID protein levels and biological activity during the immune response in mice.
Results

AID interacts with a subset of Hsp40 cochaperones and with Hsc70
Several results pointed to the interaction between AID and type I Hsp40/DjAs. A yeast two-hybrid screening using AID as bait (described in Conticello et al, 2008) yielded DnaJa2 ( Figure 1A ). Mass spectrometry then identified DnaJa1 among the proteins copurifying with AID-Flag/HA through two consecutive immunopurifications using agarose-conjugated antibodies (Orthwein et al, 2010) , which we confirmed here by coimmunoprecipitation (coIP) ( Figure 1B) . Finally, DnaJa1, a2 and a3 were pulled down with AID-GFP using anti-GFP-coated magnetic beads from extracts of stably transfected Ramos B cells (Table I) . We verified the DnaJa1-AID interaction by coIP ( Figure 1C ). CoIP also confirmed the preferential association of AID with cytoplasmic DjAs compared with DnaJb1 and DnaJb11, two of the DjB members most similar to DnaJa1 ( Figure 1D and E). We focused on DnaJa1 and DnaJa2, which are highly induced upon B-cell activation, excluding DnaJa4, which was undetectable ( Figure 1F ) and DnaJa3 because it is mitochondrial (Qiu et al, 2006) . DjAs have Zn-fingers and E. coli J-proteins non-specifically bind to DNA (Gur et al, 2005) but nuclease treatment confirmed that AID interaction with DjAs was not mediated by nucleic acids ( Figure 1G ).
We previously showed that AID interacts with Hsp90 while the AID paralogs APOBECs do not despite being up to 60% similar to AID (Orthwein et al, 2010) . Also here, AID but not APOBEC1, 2 or 3G, interacted with DnaJa1 and DnaJa2 by coIP (Figure 2A and B). The major cytosolic Hsp70 isoform, Hsc70 (encoded by HSPA8) was identified in our three pulldown experiments (Table I) . Again, Hsc70 coIP with AID but not with any of the APOBECs from transfected cells ( Figure 2C ). Interestingly, the binding of DnaJa1 or DnaJa2 to AID was not equivalent. We used AID-APOBEC2 chimeras, in which 30-50 amino acids long AID regions were replaced by the homologous APOBEC2 residues ( Figure 2D ) (Conticello et al, 2008) , to probe the interaction between AID and DjAs. Most chimeras partially or completely lost interaction with DnaJa1 while they all interacted with DnaJa2 just as well as AID ( Figure 2E and F). We can conclude that there is a specific association of AID to DjAs and the Hsp40-Hsp70 chaperoning machinery, which is not detected for the APOBEC enzymes.
DnaJa1 determines the protein levels and activity of AID in B-cell lines
The ability of both DnaJa1 and DnaJa2 to bind to overexpressed AID may not be surprising since they share B70% similarity (Supplementary Figure S1) . Notwithstanding this, several reports suggest that they are not completely redundant in their functions (Terada et al, 2005; Bhangoo et al, 2007; Tzankov et al, 2008) . We thus tested whether DnaJa1 and/or DnaJa2 were functionally relevant for AID biology, first through overexpression. We used the mouse B-cell line CH12F3 in which stimulation with anti-CD40, TGF-b1 and IL-4 induces AID and isotype switching to IgA (Nakamura et al, 1996; Muramatsu et al, 1999) . Retroviral delivery led to B2-fold overexpression of DnaJa1 or DnaJa2 in CH12F3 cells ( Figure 3A and B). Only DnaJa1 overexpression was associated with higher AID protein levels (B1.6-fold) and a significant increase in CSR ( Figure 3B and C). We obtained similar results in the chicken B-cell lymphoma line DT40, which constitutively expresses AID and undergoes Ig gene conversion (Arakawa et al, 2002) . Overexpression of DnaJa1, but not of DnaJa2, correlated with increased levels of endogenous AID ( Figure 3D and E). This was accompanied by a similar increase in the rate of Ig gene conversion as measured by a surface IgM-gain fluctuation assay ( Figure 3F ). In this assay, a proportion of AID-dependent gene conversions in the DT40 CL18 line reverses a frameshift in the IgVl, thus rescuing IgM expression (Arakawa et al, 2002 or Hsp90 had no effect on AID or Ig gene conversion in DT40 ( Figure 3D-F) . We then asked whether depletion of DnaJa1 would have the predicted opposite effect to its overexpression. We transduced CH12F3 cells with different shRNAs targeting murine DnaJa1. Each of them decreased DnaJa1 protein to a different extent (from B70 to 30% of the control; Figure 4A and B), which was mirrored by a proportional decrease in isotype switching to IgA ( Figure 4C and D) . Importantly, the relative reductions in CSR and in DnaJa1 were linearly correlated ( Figure 4E ). Depletion of DnaJa1 reduced AID protein levels ( Figure 4F ) but did not affect Aicda or Ia germline transcription, nor did it impact cell growth kinetics or Hsc70 or Hsp90 levels (Supplementary Figure S2) . In contrast, efficient knockdown of DnaJa2 in CH12F3 cells had no effect on CSR or AID protein levels ( Figure 4G-J) . Finally, DnaJa2 À B220 þ ) either resting (0) or after 1-3 days stimulation with IL-4 and LPS, analysed by western blot using antibodies against DnaJa1, DnaJa2, DnaJa4, DnaJb1 and actin. The CD43-enriched fraction (a heterogeneous mixture including T, B and other leukocytes) was included as an additional control. Exposure times vary between panels and do not accurately reflect relative abundances. (G) AID-GFP or AID-Flag/HA were immunoprecipitated in the presence of 1 mg/ml DNase and/or 0.5 mg/ml RNase using the corresponding anti-tag antibodies from lysates of HEK293T cell contransfected with Flag-DnaJa1 or Myc-DnaJa2, respectively, and analysed by western blot. depletion had no effect on AID half-life while DnaJa1 depletion reduced it by half ( Figure 4K and L). Altogether these results suggest a non-redundant and limiting role for DnaJa1 in determining the levels of functional AID partaking in its stabilization.
Compromised antibody immune response in DnaJa1-deficient mice
The only phenotype observed so far in DNAJA1 À/À mice is a defect in spermatogenesis likely due to abnormal androgen receptor signalling (Terada et al, 2005) . Our findings prompted the analysis of the antibody response in these mice. Flow cytometry analysis of lymphocyte populations showed little difference between DNAJA1 À/À and control mice lymphocyte populations. The only statistically significant changes were a 10% decrease in the proportion of follicular B cells and an B2-fold increase in marginal zone B cells in the spleen (Supplementary Figure S3 ). In contrast, there was a consistent 50% deficiency in isotype switching to IgG1 in splenic naive B cells from Figure 5A and B). The defect in CSR Figure S4) . Western blots showed a consistent 50% decrease in AID protein levels in activated B cells from each DNAJA1 À/À mouse compared with their littermate controls ( Figure 5D ). DnaJa1-deficient mice had similar IgM and IgG1 serum levels than controls ( Figure 5E ). This was expected since the long lifespan of plasma cells and antigen-mediated selection allow substantial accumulation of switched Ig isotypes in the serum of AID haploinsufficient or MSH2 À/À mice, which have defects of similar magnitude in AID levels and/or CSR as those we observe (Rada et al, 2004; Sernández et al, 2008; Takizawa et al, 2008) . DnaJa1-deficient mice had impaired response to immunization with the T-cell-dependent antigen 4-hydroxy-3-nitrophenylacetyl-conjugated chicken g globulin (NP-CGG).
There was a significant decrease in the titre of total as well as high affinity anti-NP IgG1 during the primary response in all six DNAJA1 À/À mice analysed ( Figure 5F ), demonstrating a CSR defect in vivo. By the secondary response anti-NP titres remained lower than controls in only half of them so only a non-significant trend was apparent when analysing the group ( Figure 5F ). Unlike androgen signalling defects and slightly reduced body weight, which are only found in DNAJA1 À/À males (Terada et al, 2005) , there was no sex bias for the phenotypes reported here. We conclude that DnaJa1 deficiency causes a B-cell intrinsic defect in CSR, most likely by reducing AID protein levels, thus delaying antibody immune responses. . from six independent stimulations is plotted for each population relative to the GFP controls set as 100%. (D) Endogenous AID was analysed by western blot using anti-AID on cell lysates from two representative, independently derived stable DT40 cell clones transfected with empty vector (Ctrl) or plasmids encoding myc-DnaJa1, myc-Dnaja2, myc-Hsp90 or GFP-Hsc70. Specific antibodies against each protein detected the transfected (triangles) and endogenous (circles) proteins. PCNA was used as loading control. (E) Endogenous AID levels quantified by densitometry from unsaturated western blots similar to those shown in (D) and normalized to the corresponding PCNA level. The mean value for AID in control samples set as 1 was used to normalize all values in each experiment. Data expressed as mean values±s.d. of multiple subclones for each construct are plotted (myc-DnaJa1 n ¼ 15 and myc-DnaJa2 n ¼ 21 versus controls n ¼ 18; myc-Hsp90b n ¼ 11 versus controls n ¼ 11; GFP-Hsc70 n ¼ 12 versus controls n ¼ 12). (F) Ig gene conversion frequency in transfected DT40 cells was estimated as the median proportion of IgM þ cells arising from multiple IgM À subclones after 4 weeks of clonal expansion. The proportion of sIgM þ for each subclone and median values are plotted. Different symbols indicate subclones obtained from independent transfectants. In all panels, P-values from unpaired, one-tailed t-test are indicated only for significant differences (Po0.05). À/À mice were immunized with NP 15 -CGG and serum samples collected at day 11 post-immunization (primary response). The mice were boosted at day 30 and sera collected again at day 37 (secondary response). Anti-NP IgG1 titres were determined by ELISA using plates coated with NP 26 -BSA (NP 26 column, total anti-NP antibodies) or NP 4 -BSA (NP 4 column, high affinity anti-NP antibodies). The value for each mouse is indicated, distinguishing females (triangles) and males (circles) with lines indicating median values. In all panels, P-values from paired, one-tailed Student's t-test are indicated only for statistically significant differences (Po0.05).
DnaJa1-mediated stabilization of AID depends on its farnesylation
Since we have shown that AID is an Hsp90 client (Orthwein et al, 2010) and Hsp40s partake in the Hsp90 molecular chaperoning pathway (Kimura et al, 1995; Young et al, 2004) , we sought some evidence linking DnaJa1 to Hsp90, in addition to the decrease in AID stability observed after Dnaja1 depletion (see Figure 4L) . Molecular details about the link between Hsp40 and Hsp90 in vivo are scarce but it has been shown that Ydj1 farnesylation is necessary for maintaining the protein levels of Hsp90 clients in yeast (Flom et al, 2008) . We first determined which domains of DnaJa1 mediated interaction with AID. CoIP of AID with DnaJa1 truncated variants showed that the CTDI, a Ydj1 substratebinding site (Li et al, 2003) , as well as the Zn-fingers domain were dispensable for the interaction. Indeed, deletion of the N-terminal 160 amino acids of DnaJa1 destroys the structure of both these domains ( Figure 6A and B) but still allowed AID interaction ( Figure 6C ). Mutating the farnesyl group acceptor Cys (Caplan et al, 1992) abolished the interaction of DnaJa1 with AID ( Figure 6D ). Thus, the CTDIII and farnesylation are the minimal requirements for DnaJa1 binding to AID. More importantly, while DnaJa1 expression was able to complement the CSR defect in DNAJA1 À/À B cells, expression of the DnaJa1-C394S was not able to; nor was DnaJa2 further suggesting a specific role for DnaJa1 ( Figure  6E -G). To confirm that the AID levels were dependent on farnesylated DnaJa1, we treated the Ramos human B-cell line and mouse primary B cells with the farnesyltransferase inhibitor FTI-277. Increasing doses of FTI-277 correlated with the accumulation of non-farnesylated DnaJa1 and a concomitant decrease in AID protein levels in both cases ( Figure 6H ) without affecting Aicda transcription (Supplementary Figure S5) . Furthermore, FTI treatment was able to decrease ex-vivo isotype switching to IgG1 in mouse B cells ( Figure 6I -K). Confocal microscopy of cotransfected cells showed that AID shuttled independently of DnaJa1 localization, which was not obviously affected by the C394S mutation ( Figure 6L ). In fact, DnaJa1 depletion in CH12F3 cells had no effect on AID localization or shuttling (Supplementary Figure S5) .
Taken together, these results indicate that AID biological activity levels depend on farnesylated DnaJa1 through a mechanism that determines AID protein levels in the cytoplasm.
Discussion
We have previously identified AID as an Hsp90 client, with this interaction being critical for AID stability (Orthwein et al, 2010) . We now show the interaction of AID with the Hsp40-Hsc70 system and with DnaJa1 in particular. The remarkable specificity of the functional interaction between AID and DnaJa1 in vitro and in vivo provides insight not only on AID biology but also into the functional specialization of Hsp40s.
The Hsp40-Hsp70 system delivers a subset of its substrates to the Hsp90 molecular chaperoning pathway for their functional stabilization (Young et al, 2004; Hartl et al, 2011) . Indeed, AID folding and stabilization shows similarities with the stabilization cycle of steroid hormone receptors (Picard, 2006; Hartl et al, 2011) and our results suggest the identity and function of many of the molecules involved (Orthwein et al, 2010 and this work) . DnaJa1 could act as cochaperone of Hsc70 by stimulating its ATPase activity to initiate a folding cycle that is completed by Hsp70 nucleotide exchange factors (Young et al, 2004; Kampinga and Craig, 2010; Terada and Oike, 2010) . We speculate BAG2 could be the Hsc70 nucleotide exchange factor in this cycle since it was the only one that copurified with AID (Table I) . Hsp40-Hsp70 and Hsp90 are coupled by Sti1, which has been copurified with AID (Okazaki et al, 2011) and may link the ternary AIDHsp40-Hsp70 complex to Hsp90.
Although DnaJa1 may well be an Hsc70 cochaperone during AID folding, the fact that different Hsp40s can at least partially substitute for each other in this role (Johnson and Craig, 2001; Cintron and Toft, 2006) , combined with the non-redundant function that DnaJa1 has in determining AID cellular levels in vivo, suggest that DnaJa1 may have another, more specific function. There is considerable genetic and biochemical evidence showing that Hsp40 is a functional component of some of the complexes during the Hsp90 (Caplan et al, 1995; Kimura et al, 1995; Dittmar et al, 1998; Kosano et al, 1998; Hernández et al, 2002; Wegele et al, 2006; Flom et al, 2008) . Three observations suggest that DnaJa1 has a specific role in AID stabilization and link this activity to Hsp90. First, AID is less stable in cells depleted of DnaJa1. Second, DnaJa1 farnesylation is required for binding to and optimal CSR activity of AID just as Ydj1 farnesylation is required for its interaction with Hsp90 clients (Flom et al, 2008) . Cytoplasmic type I Hsp40s are isoprenylated (Caplan et al, 1992; Kanazawa et al, 1997) . Although farnesylation targets a minor proportion of Ydj1 to intracellular membranes (Caplan et al, 1992) , this seems to be in no small part by contributing to protein-protein interactions (Marshall, 1993) . AID binding instead of the CTDI, a characterized Ydj1 substrate-binding domain (Li et al, 2003) . Coincidently, the Ydj1 mutant found to compromise Hsp90 clients stability in yeast had a single point mutation in CTDIII (Kimura et al, 1995 (Walker et al, 2010) . Interestingly, like AID, HERG stability depends on Hsp90 (Ficker et al, 2003) . It is interesting that most AID-APOBEC2 chimeras disrupt DnaJa1 binding while they all bind to DnaJa2. One could speculate that DnaJa1 recognizes a certain structure, which would be easily altered in the chimeras, while DnaJa2 may recognize less specific hydrophobic motifs present in earlier folding intermediates. Our results are compatible with some specialization of DnaJa1 to work in the Hsp90 pathway but defining this will require further work. The experiments with HERG were done in transfected HeLa cells and there is in fact hardly any data about protein levels of endogenous Hsp90 clients in the absence of a particular DjA in any system. In yeast, the Ste11 kinase levels are reduced by Ydj1 deficiency (Flom et al, 2008) . In DNAJA1 À/À mice, the androgen and glucocorticoid receptors were increased (Terada et al, 2005) while AID is reduced. This nicely illustrates the existence of different subpathways for folding/stabilization of Hsp90 clients. To the best of our knowledge, AID is the first Hsp90 client identified in higher eukaryotes that requires a specific Hsp40 to maintain its physiological levels in vivo. If DnaJa2 is not able to complement DnaJa1 deficiency and DnaJa4, the only other cytoplasmic DjA, is not expressed, it is interesting to speculate how the residual AID is folded and stabilized in vivo in DNAJA1 À/À lymphocytes. Whichever pathway forms AID in DNAJA1 À/À B cells, it is clearly not fully redundant with DnaJa1. At least in yeast, the DjB Sis1 can partially substitute for Ydj1 (Lu and Cyr, 1998; Johnson and Craig, 2001 ). Thus, a DjB like DnaJb1 or even DnaJa2 could substitute for DnaJa1 in early Hsp70-assisted AID folding; and/or it could proceed via the CCT chaperonin (Young et al, 2004; Hartl et al, 2011) . The end result is anyhow much less efficient. Therefore, we hypothesize that a later DnaJa1 role must exist in vivo, probably by linking AID to the Hsp90 pathway, and/or helping in assembling some AID complexes. This role would be more specific than, and thereby limiting, compared with protein biogenesis. The fact that the response of DNAJA1 À/À mice to immunization is so similar to the one observed in AID haploinsufficient mice (Sernández et al, 2008; Takizawa et al, 2008) suggests that the defect in CSR in vivo reflects the 50% reduction in AID rather than any other unknown defect on immune cell function. Beyond any small differences, the phenotypes of Aicda þ /À and DNAJA1 À/À mice indicate that AID can be limiting for antibody diversification and that reduced AID levels, no matter their cause, are detrimental for antibody responses, which could be exploited for therapy. We have shown that Hsp90 inhibitors could be used in this way (Orthwein et al, 2010) . DnaJa1 now offers alternative possibilities by linking AID protein levels to protein farnesylation. Farnesyltransferase inhibitors have promising anticancer activity but their relevant targets are incompletely understood (Sebti and Der, 2003) . We show that it is indeed possible to reduce AID levels and function by using farnesyltransferase inhibitors, which could have therapeutic value to modulate AID. Hsp40s are limiting components in chaperone networks. In E. coli, DnaJ is present in a 1:10 ratio with respect to DnaK (Hsp70) (Bardwell et al, 1986) . In yeast, the relative molecular proportion of Hsp82 (Hsp90), Ssa1 (Hsp70) and Ydj1 can be estimated at B4:2:1, respectively (Ghaemmaghami et al, 2003) . Hsp40s can also be functionally limiting in mammalian systems (Minami et al, 1996; Dittmar et al, 1998; Heldens et al, 2010) . We indeed see a modest increase in AID levels upon DnaJa1 overexpression. We would not expect a dramatic increase since DnaJa1 surely has many substrates and is distributed among all of them and so would be any excess DnaJa1. Considering that we achieve B2-fold increase in DnaJa1 levels, the fact that we can see an increase in AID levels and activity is significant and suggest that DnaJa1 is indeed limiting for AID folding and/or stabilization. This raises the question of whether DnaJa1 overexpression in certain cases, such as EBV infection or its association with antibody-mediated autoimmune diseases (Ramos et al, 2011) could contribute to disease by increasing AID levels.
Materials and methods
Cell lines and drug treatments
The Ramos Burkitt's B-cell lymphoma lines stably expressing GFP, AID-GFP or AID-Flag/HA have been described (Patenaude et al, 2009; Orthwein et al, 2010) . Chicken DT40 B-lymphoma cells stably expressing myc-DnaJa1, myc-DnaJa2 or myc-Hsp90b were obtained by electroporation as described (Sale et al, 2001) . GFP-Hsc70 was introduced by retroviral infection. CH12F3 mouse B cells stably expressing DnaJa1, DnaJa2, AID-GFP or empty vectors were generated by retroviral delivery of pMXs-ires-GFP or pMXs constructs and sorted for GFP-expressing cells. FTI-277 (SigmaAldrich) was diluted in water at 1 mM and stored at À201C. Cycloheximide (CHX) (Sigma-Aldrich) was freshly prepared before each experiment and diluted in EtOH at 100 mg/ml.
Identification of AID partners
The yeast two-hybrid screening has been described (Conticello et al, 2008) . Ramos B cells stably expressing AID-GFP were lysed on ice in 50 mM Tris-HCl pH 8, 150 mM NaCl, 1% Triton X-100, 5 mM MgCl 2 , 100 mg/ml RNase, 100 mg/ml DNase and complete protease inhibitors cocktail (Roche) at 3 Â10 8 cells/ml. AID was immunoprecipitated using anti-GFP-coated magnetic microbeads and MACS separation columns (Miltenyi Biotec) following the manufacturer's instructions. Eluted proteins were separated by SDS-PAGE and silver stained. Differential bands compared with the pattern obtained from Ramos cells expressing GFP only were excised and submitted to mass spectrometry for protein identification as described (Orthwein et al, 2010) .
DNA constructs
AID-GFP, AID-Flag/HA, APOBECs and Myc-Hsp90b expression vectors have been described (Orthwein et al, 2010) . Human DnaJa1 in pFlag-CMV2 was a kind gift of Dr HY Zoghbi (Baylor College of Medicine, Houston). Human Hsc70 in pEGFP-C1 was a kind gift from Dr U Stochaj (McGill University, Montreal). Human DnaJa2, 
Retroviral and lentiviral infections
Retroviral transduction of mouse primary B cells and DT40 cells was as described (Patenaude et al, 2009) . CH12F3 B cells were infected with retroviral particles obtained from the supernatant of HEK293T cell cultures cotransfected with pMXs-ires-GFP or pMXs constructs and vectors expressing MLV Gag-Pol and VSV-G envelope (2:1:1 ratio). Briefly, the retroviral supernatant was spun down at 2000 g for 90 min at 321C in Retronectin s (Takara)-coated plates before adding 5 Â10 5 CH12F3 cells and spinning at 600 g for 30 min at 321C and GFP þ cells were sorted. A similar procedure was used for lentiviral infections. Mission s DnaJa1 and DnaJa2 shRNAs (Supplementary Table SII) cloned in pLKO.1-Puro (Sigma-Aldrich) were contransfected with psPAX2 (Addgene plasmid 12260, deposited by Dr D Trono) and pVSG-G into HEK293T cells to produce lentiviral particles. An shRNA targeting luciferase and cloned in pLKO.1-Puro (Addgene plasmid 1864 deposited by Dr D Sabatini) was used as control. Cells were selected in 0.5 mg/ml puromycin 2 days post-infection.
IP and western blot
Cells were homogenized in lysis buffer (20 mM Tris, pH 8.0, 137 mM NaCl, 10% glycerol, 2 mM EDTA, 1% Triton X-100, 20 mM NaF) 48 h after transfection and extracted on ice for 10 min. The lysate was clarified for 10 min at 12 000 g at 41C and processed for western blot or IP. Typically, 2-5 Â10 6 cells were analysed by western blots to detect endogenous proteins. Tagged proteins were immunoprecipitated using either anti-Flag M2 affinity gel (SigmaAldrich) or MACS GFP Isolation kit (Miltenyi Biotech) according to the manufacturer's instructions. Eluates and lysates were analysed by western blot developed with SuperSignal West Pico Chemiluminescent substrate (Thermo Fisher Scientific). Antibodies used are in Supplementary data.
Monitoring of antibody diversification
Ig gene conversion was estimated by fluctuation assay of the proportion of cells undergoing surface IgM À to IgM þ reversion in multiple single cell-derived populations of DT40 cells after 3-week expansion at 411C. IgM expression was measured by flow cytometry using 1:200 PE-(Southern Biotech) or FITC (Bethyl)-conjugated anti-chicken IgM. IgM to IgA switching was assayed in CH12F3-2 cells activated for 3 days with 1 ng/ml TGF-b1, 10 ng/ml IL-4 and 1 mg/ml agonist anti-CD40 (BD). IgA expression was measured by flow cytometry using anti-mouse IgA-PE antibody (1:200; eBioscience). Ex-vivo isotype switching to IgG1 was assayed using resting splenic B cells purified by CD43 depletion, with CFSE loading to monitor cell division where indicated, as described (Orthwein et al, 2010) . Cells were stained with anti-IgG1-biotin (1:200; BD) followed by APC-conjugated anti-biotin (Miltenyi Biotech) and 10 mg/ml propidium iodide. For the complementation assays of DNAJA1 À/À B cells using retroviral delivery, double infection was performed at days 2 and 3 post-stimulation and isotype switching analysed at day 5.
Mice immunizations and lymphocyte populations DNAJA1
À/À mice (Terada et al, 2005) were backbred to C57Bl/6J background for at least 11 generations. In all experiments, 2-to 4-month-old, sex-matched littermates were used. DNAJA1 þ / þ and DNAJA1 þ /À served as controls as they were indistinguishable (our results and Terada et al, 2005) . Mice were immunized i.p. with 100 mg of NP 15 -CGG (Biosearch Technologies Inc., # N5055-5) in 100 ml PBS þ 100 ml of Imject Alum (Thermo Scientific) and boosted at day 30. Blood samples were collected at day À1 (preimmune), day 11 post-immunization (primary response) and day 37 (secondary response). Anti-isotype-specific antibodies were used to capture and detect total serum IgM and IgG1 in serum by ELISA. Concentrations were estimated from calibration curves made with Ig isotype standards (BD Pharmingen). Serum levels of total or high affinity anti-NP-specific IgG1 were determined by coating plates with NP 26 -BSA or NP 4 -BSA (5 mg/well), respectively. IgG1 was detected using biotynilated anti-mouse IgG1 (1:1000; BD Pharmingen) followed by HRP-conjugated streptavidin (1:5000; Thermo Scientific) and 2,2 0 -Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) substrate, detected by absorbance at 405 nm. Arbitrary units were calculated multiplying OD readings for each point of a curve made of serial twofold dilutions of the serum by the corresponding serum dilution factor. The OD 50% was defined as the anti-NP IgG1 titre for each mouse and plotted divided by 100 (NP 26 ) or 10 (NP 4 ) to have similar graphing scales. Lymphocyte populations from spleen and thymus were analysed by flow cytometry as detailed in Supplementary data. The IRCM's and Kumamoto University's animal experimentation ethics committees approved all mouse work.
IF and confocal microscopy
HeLa cells were transiently cotransfected with AID in pCDNA3.1 and either pEGFP-C3 DnaJa1 or DnaJa1-C394S using TransIT-LT1 (Mirus). Cells were treated 48 h post-transfection either by heat shocking at 431C for 90 min, or with 50 ng/ml Leptomycin B or EtOH solvent control for 2 h. Cells were processed for IF and confocal microscopy as described (Patenaude et al, 2009) , except that blocking was 5% goat serum 1 mg/ml BSA in PBS overnight at 41C and we used a mouse anti-AID MAb (clone, 1:500; Invitrogen) for 1 h followed by goat anti-mouse Alexa-680 (1:500; Invitrogen) for 30 min and imaged in an LSM 510 microscope (Zeiss) with a HeNe 633 laser. Control and DnaJa1-depleted CH12F3 cells stably expressing AID-GFP or GFP and DnaJa1 were treated with 10 ng/ml Leptomycin B or EtOH for 2 h. Cells were plated on poly-L-Lysinetreated coverslips and processed for confocal microscopy.
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
